Cormorant Asset Management, LP - Insider Non-Derivative Transactions at EyePoint Pharmaceuticals, Inc. (EYPT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 4, 2025, Cormorant Asset Management, LP's relationship to EyePoint Pharmaceuticals, Inc. (EYPT) is Other, and currently has 8,265,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other EYPT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Cormorant Asset Management, LP - Insider Non-Derivative Transactions of EYPT Common Stock

Cormorant Asset Management, LP - Insider Non-Derivative Transactions at EYPT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 5, 2025	Sell -- (Common Stock)	60000	15.7	8265000
May 7, 2024	P -- (Common Stock)	642847	11.7	8117847
May 7, 2024	P -- (Common Stock)	207153	12.36	8325000
Jan 12, 2024	P -- (Common Stock)	750000	19.75	6893235
Jan 10, 2024	P -- (Common Stock)	105000	21.32	6143235
Dec 9, 2023	P -- (Common Stock)	588235	17	6038235